Company intelligence

XGN

Exagen Inc. · NASDAQ · Healthcare

Price$7.52-1.12% · −$0.09

Market cap181.56MEquity value

P / E-9.3Trailing ratio

Volume60.53KLatest session

Market data

XGN price chart

TradingView

Related signals

1 min delayed

Browse public XGN signals with their source context and measured market impact. Open any signal for its permanent analysis page.

XGNMay 13, 2024+11.75% since signal

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

- Exagen Inc. reported a quarterly loss of $0.19 per share, beating expectations by 52.50%. - Quarterly revenues reached $14.42 million, surpassing estimates by 9.21%. - Investors question future performance, with a Zacks Rank #3 (Hold) and mixed estimate revisions. - Price Impact Rating: Bearish - Impact Horizon Rating: Short-term - Type: Earnings

View signal analysis

Research